SK completed phase III studies for new impotence drug.
SK took a joint development of SK-3530 with Intugen, a biotech venture company, since 1998 and completed the phase I study in 2004, the phase II study in Mar. 200...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
